| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $24.95 ▼ -1.06% | Yesterday | $25.33 ▲ +0.45% | Tomorrow's Kailera Therapeutics Inc. Common Stock (KLRA) setup is anchored to $25.22 and targets $24.95 (-1.06%). The near-term read is downside; watch $25.98 / $24.46 because daily realized volatility is about 5.47%. |
Tomorrow's Kailera Therapeutics Inc. Common Stock (KLRA) setup is anchored to $25.22 and targets $24.95 (-1.06%). The near-term read is downside; watch $25.98 / $24.46 because daily realized volatility is about 5.47%. | ||||
| Week | $24.39 ▼ -3.30% | Last Week | $25.57 ▲ +1.39% | The 7-day Kailera Therapeutics Inc. Common Stock model moves from $25.57 to $24.39 (-3.30%). It gives downside momentum context for this stock, so breaks around $25.98 / $24.46 matter more than a single tick. |
The 7-day Kailera Therapeutics Inc. Common Stock model moves from $25.57 to $24.39 (-3.30%). It gives downside momentum context for this stock, so breaks around $25.98 / $24.46 matter more than a single tick. | ||||
| Month | $23.45 ▼ -7.03% | Last Month | $25.96 ▲ +2.95% | The 1-month Kailera Therapeutics Inc. Common Stock target is $23.45 (-7.03%), compared with the live reference near $25.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Kailera Therapeutics Inc. Common Stock target is $23.45 (-7.03%), compared with the live reference near $25.22. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $22.04 ▼ -12.62% | Last Year | $26.56 ▲ +5.30% | The 1-year Kailera Therapeutics Inc. Common Stock scenario points to $22.04 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Kailera Therapeutics Inc. Common Stock scenario points to $22.04 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $18.73 ▼ -25.71% | 5 Years Ago | $27.94 ▲ +10.80% | The 5-year Kailera Therapeutics Inc. Common Stock view is $18.73 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Kailera Therapeutics Inc. Common Stock view is $18.73 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $25.22 | Mid |
| Daily Change | +2.48% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 62% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $25.22 | Daily Change | +2.48% |
| Market Cap | $3.10B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.